HEMOSHEAR THERAPEUTICS, INC. — Form D
HEMOSHEAR THERAPEUTICS, INC. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-14. The offering totals $8.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-14
- Form: D
- Accession: 0001846099-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $3.5M
- Remaining: $4.5M
- Investors: 4
- Date of first sale: 2023-10-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-497215
Issuer
- Name: HEMOSHEAR THERAPEUTICS, INC.
- CIK: 0001846099
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 501 LOCUST AVENUE, SUITE 301, CHARLOTTESVILLE, VA, 22902
- Phone: 434 872-0196
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| John L Brooks III | Director | Charlottesville, VA |
| David L Friedman | Director | Charlottesville, VA |
| Robert J Gould | Director | Charlottesville, VA |
| Kathleen M Metters | Director | Charlottesville, VA |
| John M Tilton | Director | Charlottesville, VA |
| Brian M Warmhoff | Director | Charlottesville, VA |
| H. Thomas Watkins III | Director | Charlottesville, VA |
| Aric Holsinger | Executive Officer | Charlottesville, VA |
| Patrick A Horn | Executive Officer | Charlottesville, VA |
| Michael A Innes | Executive Officer | Charlottesville, VA |
| Brian A Johns | Executive Officer | Charlottesville, VA |
| Brian M Warmhoff | Executive Officer | Charlottesville, VA |
| Brian Thomas Wamhoff | Executive Officer | CHARLOTTESVILLE, VA |
| W. M Thompson, Jr. | Executive Officer | CHARLOTTESVILLE, VA |
| John A Tilton | Director | CHARLOTTESVILLE, VA |
| James C Powers | Director | CHARLOTTESVILLE, VA |
| James C Powers | Executive Officer | CHARLOTTESVILLE, VA |
| Aric R Holsinger | Executive Officer | CHARLOTTESVILLE, VA |
| John L Brooks | Director | CHARLOTTESVILLE, VA |
| DAVID A FRIEDMAN | Director | EVANSTON, IL |
Other filings by this issuer (1)
More